Go to navigation Go to content
Toll-Free: 800-752-0042
Phone: 757-460-7776
Shapiro & Appleton

France Suspended Prescribing Actos

Comments (0)
On June 13, 2011, Takeda, the maker of diabetes drugs Actos (pioglitazone) and Competact (pioglitazone and metformin) announce the French regulatory authorities informed it that they intended to suspend the use of the medications in the country. The move would mean doctors could no longer prescribe the drug products to new patients.

The ban on pioglitazone-containing medications was based on a study that showed an increased risk of bladder cancer in patients treated with pioglitazone for longer than a year. A pan-European review of pioglitazone safety began in March 2011.

In the United States, Takeda is funding a 10-year epidemiological study that began in 2002.

Our law firm holds drug manufacturers accountable for drugs' adverse effects, and strives to keep residents of North Carolina and Virginia updated when it hears of allegedly defective drugs
Contact Shapiro & Appleton if you or a loved one suffers injuries from Actos.  

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.

Avvo The Best lawyers in America Super lawyers Best Law Firms US News Verdicts and Settlements AV LexisNexis

Live Chat